Prof. Dr. Thomas Gerber, the creator of NanoBone and former head of Nanostructured Materials at the University of Rostock Institute for Physics in Germany, is a leading expert in nanotechnology focused on the biology of bone graft substitutes.
In 2015, Artoss, Inc. was established by Paul Byerley and James Cassidy, Ph.D., with the aim of commercializing NanoBone in North America. The commencement of NanoBone commercialization in the U.S. took place in 2016 after receiving its initial FDA clearance. Since its introduction, NanoBone has experienced significant market adoption and growth, being utilized in over 100,000 cases across various orthopedic specialties in both the U.S. and EU.